Northwestern Mutual Wealth Management CO Idera Pharmaceuticals, Inc. Transaction History

Northwestern Mutual Wealth Management CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	BUY	$1.45 - $2.79 $3,625 - $6,975	2,500 New	2,500 $5,000
Q2 2019 Aug 12, 2019	SELL	$2.37 - $3.97 $5,925 - $9,925	-2,500 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$2.77 - $9.38 $6,925 - $23,450	2,500 New	2,500 $7,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.